Search Results - "Pereira, Joao P Belo"

Targeted proteomics improves cardiovascular risk prediction in secondary prevention by Nurmohamed, Nick S., Belo Pereira, João P., Hoogeveen, Renate M., Kroon, Jeffrey, Kraaijenhof, Jordan M., Waissi, Farahnaz, Timmerman, Nathalie, Bom, Michiel J., Hoefer, Imo E., Knaapen, Paul, Catapano, Alberico L., Koenig, Wolfgang, de Kleijn, Dominique, Visseren, Frank L.J., Levin, Evgeni, Stroes, Erik S.G.

“…Abstract Aims Current risk scores do not accurately identify patients at highest risk of recurrent atherosclerotic cardiovascular disease (ASCVD) in need of…”
Get full text

Multiomics Analysis Provides Novel Pathways Related to Progression of Heart Failure by Ouwerkerk, Wouter, Belo Pereira, Joao P., Maasland, Troy, Emmens, Johanna E., Figarska, Sylwia M., Tromp, Jasper, Koekemoer, Andrea L., Nelson, Christopher P., Nath, Mintu, Romaine, Simon P.R., Cleland, John G.F., Zannad, Faiez, van Veldhuisen, Dirk J., Lang, Chim C., Ponikowski, Piotr, Filippatos, Gerasimos, Anker, Stefan, Metra, Marco, Dickstein, Kenneth, Ng, Leong L., de Boer, Rudolf A., van Riel, Natal, Nieuwdorp, Max, Groen, Albert K., Stroes, Erik, Zwinderman, Aeilko H., Samani, Nilesh J., Lam, Carolyn S.P., Levin, Evgeni, Voors, Adriaan A.

“…BACKGROUNDDespite major advances in pharmacological treatment for patients with heart failure, residual mortality remains high. This suggests that important…”
Get full text

Predictive value of targeted proteomics for coronary plaque morphology in patients with suspected coronary artery disease by Bom, Michiel J., Levin, Evgeni, Driessen, Roel S., Danad, Ibrahim, Van Kuijk, Cornelis C., van Rossum, Albert C., Narula, Jagat, Min, James K., Leipsic, Jonathon A., Belo Pereira, João P., Taylor, Charles A., Nieuwdorp, Max, Raijmakers, Pieter G., Koenig, Wolfgang, Groen, Albert K., Stroes, Erik S.G., Knaapen, Paul

“…Risk stratification is crucial to improve tailored therapy in patients with suspected coronary artery disease (CAD). This study investigated the ability of…”
Get full text

Improved cardiovascular risk prediction using targeted plasma proteomics in primary prevention by Hoogeveen, Renate M, Pereira, João P Belo, Nurmohamed, Nick S, Zampoleri, Veronica, Bom, Michiel J, Baragetti, Andrea, Boekholdt, S Matthijs, Knaapen, Paul, Khaw, Kay-Tee, Wareham, Nicholas J, Groen, Albert K, Catapano, Alberico L, Koenig, Wolfgang, Levin, Evgeni, Stroes, Erik S G

“…Abstract Aims In the era of personalized medicine, it is of utmost importance to be able to identify subjects at the highest cardiovascular (CV) risk. To date,…”
Get full text

Differential DNA methylation in familial hypercholesterolemia by Reeskamp, Laurens F., Venema, Andrea, Pereira, Joao P. Belo, Levin, Evgeni, Nieuwdorp, Max, Groen, Albert K., Defesche, Joep C., Grefhorst, Aldo, Henneman, Peter, Hovingh, G. Kees

“…Familial hypercholesterolemia (FH) is a monogenic disorder characterized by elevated low-density lipoprotein cholesterol (LDL-C). A FH causing genetic variant…”
Get full text

A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOX by Stroes, Charlotte I, Schokker, Sandor, Molenaar, Remco J, Mathôt, Ron A A, Bijlsma, Maarten F, van der Woude, Stephanie O, Belo Pereira, João P, Hooijer, Gerrit K J, Verhoeven, Rob H A, Cats, Annemieke, Grootscholten, Cecile, van Sandick, Johanna W, Creemers, Geert-Jan, Nieuwenhuijzen, Grard A P, Haj Mohammad, Nadia, Ruurda, Jelle P, Meijer, Sybren L, Hulshof, Maarten C C M, van Berge Henegouwen, Mark I, van Laarhoven, Hanneke W M

“…We assessed the feasibility of adjuvant S-1 and oxaliplatin following neoadjuvant chemoradiotherapy (nCRT) and esophagectomy. Patients treated with nCRT…”
Get full text

TARGETED PROTEOMICS IMPROVES CARDIOVASCULAR RISK PREDICTION IN SECONDARY PREVENTION PATIENTS by Nurmohamed, Nick S., Pereira, Joao P. Belo, Hoogeveen, Renate M., Kroon, Jeffrey, Kraaijenhof, Jordan M., Waissi, Farahnaz, Timmerman, Nathalie, Bom, Michiel, Hoefer, Imo, Knaapen, Paul, Catapano, Alberico L., Koenig, Wolfgang, de Kleijn, Dominique, Visseren, Frank, Levin, Evgeni, Stroes, Erik S.G.

Get full text

Multi-omics analysis provides novel pathways related to progression of heart failure by Ouwerkerk, Wouter, Pereira, Joao P Belo, Maasland, Troy, Emmens, Johanna E, Figarska, Sylwia M, Tromp, Jasper, Koekemoer, Andrea L, Nelson, Christopher P, Nath, Mintu, Romaine, Simon P R, Cleland, John Gf, Zannad, Faiez, van Veldhuisen, Dirk J, Lang, Chim C, Ponikowski, Piotr, Filippatos, Gerasimos, Anker, Stefan, Metra, Marco, Dickstein, Kenneth, NG, Leong, de Boer, Rudolf A, van Riel, Natal, Nieuwdorp, Max, Groen, Albert K, Stroes, Erik, Zwinderman, Aeilko H, Samani, Nilesh J, Lam, Carolyn Sp, Levin, Evgeni, Voors, Adriaan A

Get full text

Predictive value of targeted proteomics for coronary plaque morphology in patients with suspected coronary artery diseaseResearch in context by Michiel J. Bom, Evgeni Levin, Roel S. Driessen, Ibrahim Danad, Cornelis C. Van Kuijk, Albert C. van Rossum, Jagat Narula, James K. Min, Jonathon A. Leipsic, João P. Belo Pereira, Charles A. Taylor, Max Nieuwdorp, Pieter G. Raijmakers, Wolfgang Koenig, Albert K. Groen, Erik S.G. Stroes, Paul Knaapen

“…Background: Risk stratification is crucial to improve tailored therapy in patients with suspected coronary artery disease (CAD). This study investigated the…”
Get full text

Abstract 14485: Predictive Value of Targeted Proteomics for Coronary Plaque Morphology in Patients With Stable Coronary Artery Disease by Bom, Michiel J, Levin, Evgeni, Driessen, Roel S, Danad, Ibrahim, van Kuijk, Cornelis C, van Rossum, Albert C, Narula, Jagat, Min, James K, Leipsic, Jonathon A, Belo Pereira, João P, Taylor, Charles A, Nieuwdorp, Max, Raijmakers, Pieter G, Koenig, Wolfgang, Groen, Albert K, Stroes, Erik S, Knaapen, Paul

“…IntroductionRisk stratification in patients with coronary artery disease (CAD) is crucial to identify patients at risk for future events. Recently, the…”
Get full text